Live Breaking News & Updates on Catina Oleary|Page 1

The EMA now requires Plain Language Summaries (PLS) for clinical trials with sites in the EU. The FDA has no current regulations for PLS, but they. ....

United States , Deborah Collyar , Catina Oleary , Clinical Trials Expert Group , Development Of Duchenne Video Assessment , European Parliament , Drug Administration , Drug Development , Patient Advocates In Research , Us National Library Of Medicine , Health Literacy Media , European Union , European Medicines Agency , National Academies Of Sciences , National Academies , Mat Stevens , Plain Language Summaries , Patient Focused Drug Development , Patient Reported Outcomes , Focused Drug Development Guidance Series , Medical Product Development , Regulatory Decision , Lay Summary Practice , Duchenne Video Assessment , Sector Average Rating Worst , Medlineplus Medical Encyclopedia ,